Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled trial of Shiwei Shufeng Granules for acute eczema with damp-heat pattern
CTR20261646Phase 2Active
- Sponsor
- Shandong Institute of Pharmaceutical Industry
- Start
- May 2026
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Shiwei Shufeng Granules in atopic dermatitis (AD), sponsored by Shandong Institute of Pharmaceutical Industry. Started May 2026; status: active.
02
Drugs
Shiwei Shufeng Granules
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on CTR20261646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261646.